Do you need to be encouraged to exercise faith by preparing to take risks? If so, then this book is for you. Prescription Impossible describes experiences of working out the life of faith in the land of startling contrasts that is Thailand.* The author?s experience as a missionary and a pharmacy academic in Thailand gives a flavour of student ministry in a missionary context.* His working as a Buddhist government employee indicates the rewards and demands of such an avenue of service.* Examples of the necessity of organised prayer support are scattered throughout the book.

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

Getting the right diagnosis is a key aspect of health care - it provides an explanation of a patient's health problem and informs subsequent health care decisions. The diagnostic process is a complex, collaborative activity that involves clinical reasoning and information gathering to determine a patient's health problem. According to Improving Diagnosis in Health Care, diagnostic errors-inaccurate or delayed diagnoses-persist throughout all settings of care and continue to harm an unacceptable number of patients. It is likely that most people will experience at least one diagnostic error in their lifetime, sometimes with devastating consequences. Diagnostic errors may cause harm to patients by preventing or delaying appropriate treatment, providing unnecessary or harmful treatment, or resulting in psychological or financial repercussions. The committee concluded that improving the diagnostic process is not only possible, but also represents a moral, professional, and public health imperative. Improving Diagnosis in Health Care, a continuation of the landmark Institute of Medicine reports To Err Is Human (2000) and Crossing the Quality Chasm (2001), finds that diagnosis-and, in particular, the occurrence of diagnostic errorsâ€"has been largely unappreciated in efforts to improve the quality and safety of health care. Without a dedicated focus on improving diagnosis, diagnostic errors will likely worsen as the delivery of health care and the diagnostic process continue to increase in complexity. Just as the diagnostic process is a collaborative activity, improving diagnosis will require collaboration and a widespread commitment to change among health care professionals, health care organizations, patients and their families, researchers, and policy makers. The recommendations of Improving Diagnosis in Health Care contribute to the growing momentum for change in this crucial area of health care quality and safety.

Second in a series of publications from the Institute of Medicine's Quality of Health Care in America project Today's health care providers have more research findings and more technology available to them than ever before. Yet recent reports have raised serious doubts about the quality of health care in America. Crossing the Quality Chasm makes an urgent call for fundamental change to close the quality gap. This book recommends a sweeping redesign of the American health care system and provides overarching principles for specific direction for policymakers, health care leaders, clinicians, regulators, purchasers, and others. In this comprehensive volume the committee offers: A set of performance expectations for the 21st century health care system. A set of 10 new rules to guide patient-clinician relationships. A suggested organizing framework to better align the incentives inherent in payment and accountability with improvements in quality. Key steps to promote evidence-based practice and strengthen clinical information systems. Analyzing health care organizations as complex systems, Crossing the Quality Chasm also documents the causes of the quality gap, identifies current practices that impede quality care, and explores how systems approaches can be used to implement change.

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.

You’re faced with a difficult health condition. You have exhausted medicine’s answers. What do you do? Susannah Meadows tells the real-life stories of seven families who persisted when traditional medicine alone wasn’t enough. Their adventures take us to the outer frontiers of medical science and cutting-edge complementary therapies, as Meadows explores research into the mind’s potential to heal the body, the possible role food may play in reversing disease, the power of agency, perseverance, and hope—and more. When journalist Susannah Meadows noticed her three-year-old son, Shepherd, shying away from soccer practice, she had no idea it was the first sign of juvenile idiopathic arthritis. The diagnosis was the first step of a long journey, physically painful for Shepherd and emotionally wrenching for Susannah and her family. But they pressed on, and using a combination of traditional and complementary medicine they beat the disease, and the odds. Meadows chronicles her own story, and takes you into the lives of other remarkable people, exploring their heartbreaks and triumphs. One boy who has severe food allergies undergoes an unconventional therapy and is soon eating everything. An organic farmer in Washington State tries to solve the puzzle of her daughter’s epileptic seizures. A physician with MS creates her own combination of treatments and goes from a wheelchair to riding a bike again. A child diagnosed with ADHD refuses to take medication and instead improves his life, and the life of his family, after changing his diet. Other families take on rheumatoid arthritis and autistic behaviors. Meadows includes new information about traditional and nontraditional medicine and the latest science on how the health of our gut bacteria is connected to wellness—and how the right foods play a key role in helping this microscopic population thrive. She also talks with scientists who study the traits and circumstances that may make some people keep going when others feel helpless. These researchers are illuminating the psychology of healing—how the mind, and asserting control over your body and health, can play a part in recovery. Fascinating, moving, and profoundly inspiring, The Other Side of Impossible gives us people driven by love, desperation, and astonishing resolve—a community of the defiant who share an extraordinary talent for hope and for fighting the battle for healing in today’s world and tomorrow’s.